Precigen Inc

PGEN

Company Profile

  • Business description

    Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

  • Contact

    20374 Seneca Meadows Parkway
    GermantownMD20876
    USA

    T: +1 301 556-9900

    E: [email protected]

    http://www.precigen.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    25

Stocks News & Analysis

stocks

Goldman Sachs Earnings: Valuations remain stretched

We raise our fair value estimate for Goldman Sachs stock.
stocks

Major ASX listed miners overvalued

We’ve adjusted our fair values after updating our commodity price assumptions.
stocks

Undervalued ASX share with pathway to positive cash flow

Higher sales and a new loan facility increase our conviction.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,194.9012.40-0.13%
CAC 408,134.76124.18-1.50%
DAX 4024,999.83297.30-1.18%
Dow JONES (US)49,359.3383.11-0.17%
FTSE 10010,190.6144.68-0.44%
HKSE26,563.90281.06-1.05%
NASDAQ23,515.3914.63-0.06%
Nikkei 22553,583.57352.60-0.65%
NZX 50 Index13,580.29137.81-1.00%
S&P 5006,940.014.46-0.06%
S&P/ASX 2008,874.509.20-0.10%
SSE Composite Index4,114.0012.090.29%

Market Movers